The Board and management have for a long period developed iZafe Group's vision and strategy. We are now presenting it to shareholders and stakeholders to create an understanding of where iZafe Group is heading as a company.

Today, the company offers a product, Dosell, which is based on ensuring the right medicine at the right time via sachets. However, the importance of good adherence applies to more than those who receive medication via sachets. By broadening our offer from manual medicine management in the mobile app to a comprehensive offer that automates the entire flow with Dosell, iZafe Group becomes the company that helps everyone to take the right medicine at the right time.
 
Our new vision is therefore "health thanks to good adherence."
 
To achieve this, we will develop a comprehensive range of digital services and products that ensure that the right medicine is taken at the right time with the goal of being able to clearly show the health effects of adherence combined with values from other sensors:

  • Our app is the basis for all solutions that can be used together with Dosell, other devices or as a standalone service and should remind and ensure adherence regardless of whether the medicines are packaged in sachets, pill jars, injection, tablet, or in liquid form. It shall also keep statistics and possibly alert in the event of no medication. Alarms can reach the user as well as relatives and / or care staff.
  • Sorting in a container for medicines where we offer a smartly connected version that with the help of our app helps with sorting, reminders, statistics and alarms to selected people in case of missed medication.
  • Medicine in a sachet where we, with the help of Dosell, automate all aspects of the medication.

In this way, we get access to a large amount of data that will help us understand our customers, know when to offer the user products to ensure adherence, create opportunities for new collaborations and a basis for doctors regarding future care interventions or changes in medication.
 
Adherence data is also an important basis for pharmaceutical companies and other stakeholders conducting clinical studies. Therefore, these stakeholders are also a potential stakeholder for iZafe Group.
 
“We are now entering a new phase of our journey towards becoming a market leader to improve adherence and thus health. We must ensure that everyone who medicates has the best conditions to take the right medicine at the right time through smart, digital and modern solutions. During the rest of 2022, we will be able to see several interesting updates in our company to ensure that this further development goes according to plan. We look forward to being able to communicate them in the near future.” says Joachim Källsholm, Chairman of the Board of iZafe Group AB.
 
Linked to the new strategy, several changes are now being implemented within the organization. With the new direction that the company is taking, the board has agreed together with vice president and commercial director Tobias Johansson to go their separate ways.
 
iZafe Group has chosen to recruit Henrik Windahl as Business Unit Manager, who will start on May 30. Henrik's background and extensive experience in partner sales and business development will help to take the company's sales of Dosell to the levels needed to be able to take the next step in iZafe Group's development and success both nationally and internationally.
 
Read iZafe Group's new company narrative here.

iZafe Group AB (publ) – announces that in connection with the interim report for the first quarter of 2022, which will be published at 08:30 CET on April 29, 2022, shareholders, media, and other stakeholders will be given the opportunity to ask questions to the company.

The questions will be answered by CEO Anders Segerström and published on iZafe Group's investor page on May 9, 2022, under the heading financial reports, investor questions.

Please send your questions to before 10:00 CET (10 a.m.) on May 4, 2022.

iZafe Group (publ.) hereby announces that the partner Zafe Care Systems AB has now begun implementation of 2 Dosell in a municipality in northern Sweden.

The municipality, which has about 2,650 inhabitants who are 65 years and older, initially starts with 2 Dosell with an ambition to increase the number gradually.
 
About Zafe
Zafe Care Systems AB, which was acquired by the AddLife Group, is part of Home Care, similar to Norwegian Hepro, and is one of the leading companies in welfare technology on the Swedish market. Their main customers are the state, municipalities and aid centers. Today, they work with more than 200 municipalities and are suitable thanks to their market-leading technology in all types of care homes.
 
About Dosell
The medicinal robot Dosell is a Swedish-made digital aid for safer medication at home and for people living in nursing homes. Dosell is integrated into welfare platforms and is sold as one of several integrated digital aids via partners.
In a Swedish report, it is estimated that 3,000 Swedes die annually from drug-related injuries and that 6–16 percent of hospital admissions are drug-related. The costs for drug-related injuries that can be avoided are estimated at SEK 5.6–24.6 billion per year.
Dosell notifies the patient when it's time to take the medicine, and if the medicine is not taken despite the reminders, Dosell alerts healthcare professionals or relatives who can quickly prevent an injury and improve compliance, thus minimizing drug-related injuries.
Read more at www.dosell.se

iZafe Group (publ.) hereby announces that the partner Hepro AS has now starting implementation of 2 Dosell in a municipality in the southern region of Norway.

The municipality, which has about 3,700 inhabitants who are 65 years and older, initially starts with 2 Dosell with an ambition to increase the number gradually.
 
 
About Hepro
HEPRO AS is a modern and future-oriented competence company that develops, produces and sells aids and welfare technology of high quality and clean design. The company was founded in 1987 and has extensive experience in developing products and solutions that will make everyday life easier for their customers. Their vision is to give their customers the opportunity to manage themselves, participate actively in their own everyday lives and stay longer at home. Hepro is owned by the Stockholm-based listed AddLife Group. AddLife has approx. 70 st. independent subsidiaries and over 1800 employees.
 
About Dosell
The medicinal robot Dosell is a Swedish-made digital aid for safer medication at home and for people living in nursing homes. Dosell is integrated into welfare platforms and is sold as one of several integrated digital aids via partners.
In a Swedish report, it is estimated that 3,000 Swedes die annually from drug-related injuries and that 6–16 percent of hospital admissions are drug-related. The costs for drug-related injuries that can be avoided are estimated at SEK 5.6–24.6 billion per year.
Dosell notifies the patient when it's time to take the medicine, and if the medicine is not taken despite the reminders, Dosell alerts healthcare professionals or relatives who can quickly prevent an injury and improve compliance, thus minimizing drug-related injuries.
Read more at www.dosell.se

iZafe Group (publ.) hereby announces that the partner Careium AB has now begun implementation of 6 Dosell in a municipality in western Sweden.

The municipality, which has about 3,000 inhabitants who are 65 years and older, initially starts with 6 Dosell.
 
About Careium
Careium is today the market leader in welfare technology in Europe and approximately 400,000 people use their services. The vast majority of these are connected to one of their six alarm centers in Sweden, Norway and the United Kingdom. The alarm centers receive more than 30,000 alarms a day.
Doro Care recently changed its name to Careium. Doro acquired Caretech in 2014, which became the starting point for what today is Careium.
 
About Dosell
The medicinal robot Dosell is a Swedish-made digital aid for safer medication at home and for people living in nursing homes. Dosell is integrated into welfare platforms and is sold as one of several integrated digital aids via partners.
In a Swedish report, it is estimated that 3,000 Swedes die annually from drug-related injuries and that 6–16 percent of hospital admissions are drug-related. The costs for drug-related injuries that can be avoided are estimated at SEK 5.6–24.6 billion per year.
Dosell notifies the patient when it's time to take the medicine, and if the medicine is not taken despite the reminders, Dosell alerts healthcare professionals or relatives who can quickly prevent an injury and improve compliance, thus minimizing drug-related injuries.
Read more at www.dosell.se

iZafe Group (publ.) hereby announces that the partner Hepro AS has now starting implementation of 25 Dosell in a municipality in the western region of Norway.

The municipality, which has about 3,300 inhabitants who are 65 years and older, initially starts with 25 Dosell and then gradually increases the number with an ambition of 100 Dosell within a year.
 
About Hepro
HEPRO AS is a modern and future-oriented competence company that develops, produces and sells aids and welfare technology of high quality and clean design. The company was founded in 1987 and has extensive experience in developing products and solutions that will make everyday life easier for their customers. Their vision is to give their customers the opportunity to manage themselves, participate actively in their own everyday lives and stay longer at home. Hepro is owned by the Stockholm-based listed AddLife Group. AddLife has approx. 70 st. independent subsidiaries and over 1800 employees.
 
About Dosell
The medicinal robot Dosell is a Swedish-made digital aid for safer medication at home and for people living in nursing homes. Dosell is integrated into welfare platforms and is sold as one of several integrated digital aids via partners.
In a Swedish report, it is estimated that 3,000 Swedes die annually from drug-related injuries and that 6–16 percent of hospital admissions are drug-related. The costs for drug-related injuries that can be avoided are estimated at SEK 5.6–24.6 billion per year.
Dosell notifies the patient when it's time to take the medicine, and if the medicine is not taken despite the reminders, Dosell alerts healthcare professionals or relatives who can quickly prevent an injury and improve compliance, thus minimizing drug-related injuries.
Read more at www.dosell.se

iZafe Group (publ.) hereby announces that CEO Anders Segerström will present on March 31 at 12.35 on Redeye's theme day: Digital Health Day

The broadcast is live and can be followed at https://www.redeye.se/events/830579/redeye-theme-digital-health-day where the presentation will also be available to watch afterwards.

iZafe Group (publ.) hereby announces that the partner Remedio S.R.L is ready with its pilot of Dosell which will be included in its concept Sempli Farma. An initial order for 50 Dosell will be sent to Italy this week.

“We have for a long time tested and evaluated Dosell together with the Sempli Farma concept, which enables a safer and simpler medication at home together with the local pharmacy. In connection with all parts now being in place, I have brought in a commercial team of 3 people who will actively work with sales to the 20,000 pharmacies in Italy, and also find partners that will offer Sempli Farma including Dosell in its portfolios” says Alessando Iadecola, CEO Remedio S.R.L.
 
"We are very pleased with this news for several reasons. We think that the concept is very exciting where you are not limited by the sachet market as the sachets are included as part of the service and we see great potential for similar concepts in other countries. And that the Italian market has a huge potential where there are over 8.8 million people who are over 65 and take more than 5 medicines a day.
With EUR 20 billion in annual costs linked to incorrect medication in Italy, we hope that the Sempli Farma concept can contribute to safer care where lives are saved and injuries avoided, as well as saving large costs for society.” says Anders Segerström, CEO of iZafe Group AB.
 
About Sempli Farma by Remedio S.R.L
The Italian healthcare company Remedio has built a network of strategically selected partners in Italy to find a combination of different aids in drug management and distribution channels that enable the elderly to stay at home longer. Unlike in Sweden, the possibility of receiving medicine on a dose roll has not existed in Italy; this has inspired Remedio to launch the concept of sachets and develop the complete solution Sempli Farma.
 
Sempli Farma is a service that connects pharmacists with the patient and their relatives via a pharmacy through a closed system for drug dispensing. The care concept aims to reduce care costs and streamline the Italian healthcare system. Dosell becomes the ultimate end component by delivering the dose bags while at the same time the compliance of the medication can be checked and statistics obtained.

About Dosell
The medicinal robot Dosell is a Swedish-made digital aid for safer medication at home and for people living in nursing homes. Dosell is integrated into welfare platforms and is sold as one of several integrated digital aids via partners.
In a Swedish report, it is estimated that 3,000 Swedes die annually from drug-related injuries and that 6–16 percent of hospital admissions are drug-related. The costs for drug-related injuries that can be avoided are estimated at SEK 5.6–24.6 billion per year.
Dosell notifies the patient when it's time to take the medicine, and if the medicine is not taken despite the reminders, Dosell alerts healthcare professionals or relatives who can quickly prevent an injury and improve compliance, thus minimizing drug-related injuries.
Read more at www.dosell.se

iZafe Group (publ.) hereby announces that the partner Zafe Care Systems AB has now begun implementation of 15 Dosell in a municipality in southern Sweden.

The municipality, which has about 14,800 inhabitants who are 65 years and older, initially starts with 15 Dosell with an ambition to increase the number gradually.
 
About Zafe
Zafe Care Systems AB, which was acquired by the AddLife Group, is part of Home Care, similar to Norwegian Hepro, and is one of the leading companies in welfare technology on the Swedish market. Their main customers are the state, municipalities and aid centers. Today, they work with more than 200 municipalities and are suitable thanks to their market-leading technology in all types of care homes.
 
About Dosell
The medicinal robot Dosell is a Swedish-made digital aid for safer medication at home and for people living in nursing homes. Dosell is integrated into welfare platforms and is sold as one of several integrated digital aids via partners.
In a Swedish report, it is estimated that 3,000 Swedes die annually from drug-related injuries and that 6–16 percent of hospital admissions are drug-related. The costs for drug-related injuries that can be avoided are estimated at SEK 5.6–24.6 billion per year.
Dosell notifies the patient when it's time to take the medicine, and if the medicine is not taken despite the reminders, Dosell alerts healthcare professionals or relatives who can quickly prevent an injury and improve compliance, thus minimizing drug-related injuries.
Read more at www.dosell.se

iZafe Group (publ.) hereby announces that the partner Hepro AS has now starting implementation of 5 Dosell in a municipality in the northern region of Norway.

The municipality, which has about 640 inhabitants who are 65 years and older, initially starts with 5 Dosell with an ambition to increase the number gradually.
 
About Hepro
HEPRO AS is a modern and future-oriented competence company that develops, produces and sells aids and welfare technology of high quality and clean design. The company was founded in 1987 and has extensive experience in developing products and solutions that will make everyday life easier for their customers. Their vision is to give their customers the opportunity to manage themselves, participate actively in their own everyday lives and stay longer at home. Hepro is owned by the Stockholm-based listed AddLife Group. AddLife has approx. 70 st. independent subsidiaries and over 1800 employees.
 
About Dosell
The medicinal robot Dosell is a Swedish-made digital aid for safer medication at home and for people living in nursing homes. Dosell is integrated into welfare platforms and is sold as one of several integrated digital aids via partners.
In a Swedish report, it is estimated that 3,000 Swedes die annually from drug-related injuries and that 6–16 percent of hospital admissions are drug-related. The costs for drug-related injuries that can be avoided are estimated at SEK 5.6–24.6 billion per year.
Dosell notifies the patient when it's time to take the medicine, and if the medicine is not taken despite the reminders, Dosell alerts healthcare professionals or relatives who can quickly prevent an injury and improve compliance, thus minimizing drug-related injuries.
Read more at www.dosell.se

Webbdesign av Comlog Webbyrå Stockholm